Silver Intel Report
Miner Company

Biotech firm Odyssey raises $279 million in upsized US IPO

By Reuters May 07, 2026 Bullish
Biotech firm Odyssey raises $279 million in upsized US IPO
Biopharmaceutical ​company ‌Odyssey Therapeutics ​has ​raised $279 ⁠million ​in its ​upsized U.S. ​initial ​public offering, ‌the ⁠company said ​on ​Thursday.
Biopharmaceutical ​company ‌Odyssey Therapeutics ​has ​raised $279 ⁠million ​in its ​upsized U.S. ​initial ​public offering, ‌the ⁠company said ​on ​Thursday.